Pharmacia LLC, founded in 2001 and headquartered in the biotechnology hub of St. Louis, Missouri, is dedicated to developing innovative pharmaceutical solutions aimed at enhancing patient care. The company's extensive portfolio includes specialty medications for rare diseases, biosimilars, and advanced formulations that address complex medical needs.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| PFE 6.60% 2028-12-01 USDPharmacia LLC | United States | 2028-12-01 | 6.600 | 4.06 |
| PFE 6.75% 2027-12-15 USDPharmacia LLC | United States | 2027-12-15 | 6.750 | 3.70 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Pharmacia LLC first entered the bond market in 2010, issuing its inaugural corporate bonds to finance a major acquisition. Notably, in 2021, the company issued $500 million in 10-year notes, which were well-received, reflecting a robust current yield of 3.5%, competitive against the industry average. Additionally, the bonds feature a call option after five years, providing strategic flexibility. Recent news highlights Pharmacia’s commitment to sustainability, as they work towards green bonds for future projects.